EBITDA for Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's current EBITDA (TTM) is $1.46B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ILMN
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$1.46B
YoY change
-301.0%
5Y CAGR
+5.9%
Peak year (2025)
$1.46B
Cumulative EBITDA
$5.68B
EBITDA history chart for Illumina (ILMN) from 1999 to 2025
EBITDA history table for Illumina (ILMN) from 1999 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $1.46B | -301.0% | ||
| 2024 | -$725.00M | +19.2% | ||
| 2023 | -$608.00M | -84.5% | ||
| 2022 | -$3.92B | -427.4% | ||
| 2021 | $1.20B | +9.5% | ||
| 2020 | $1.09B | -19.6% | ||
| 2019 | $1.36B | +20.2% | ||
| 2018 | $1.13B | -8.6% | ||
| 2017 | $1.24B | +68.2% | ||
| 2016 | $735.00M | -2.4% | ||
| 2015 | $753.00M | +24.9% | ||
| 2014 | $603.06M | +103.1% | ||
| 2013 | $296.93M | -8.8% | ||
| 2012 | $325.71M | +37.4% | ||
| 2011 | $237.03M | -5.9% | ||
| 2010 | $251.99M | +49.1% | ||
| 2009 | $169.03M | +37.8% | ||
| 2008 | $122.62M | +580.7% | ||
| 2007 | $18.01M | -58.6% | ||
| 2006 | $43.52M | -2737.6% | ||
| 2005 | -$1.65M | +220.4% | ||
| 2004 | -$515,000 | -97.3% | ||
| 2003 | -$19.19M | -40.7% | ||
| 2002 | -$32.35M | +43.4% | ||
| 2001 | -$22.56M | +40.6% | ||
| 2000 | -$16.04M | +229.8% | ||
| 1999 | -$4.86M | — |
EBITDA values are taken from Illumina's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Illumina (ILMN) most recent annual EBITDA stands at $1.46B (2025) – plunged 301.0% year-over-year.
Illumina EBITDA has recorded the values shown across consecutive periods, with a +5.9% compound annual growth rate over 2020–2025 (5 years).
The dataset's maximum EBITDA sits at $1.46B (2025); the minimum reading of -$3.92B dates to 2022.
Within Healthcare, Illumina (ILMN) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Illumina EBITDA by Year
Illumina EBITDA 2025: $1.46B
Illumina EBITDA in 2025 was $1.46B, plunged 301.0% below 2024. This figure represents the highest annual value in the available history.
Illumina EBITDA 2024: -$725.00M
Illumina EBITDA in 2024 was -$725.00M, grew 19.2% from 2023.
Illumina EBITDA 2023: -$608.00M
Illumina EBITDA in 2023 was -$608.00M, plunged 84.5% below 2022.
Illumina EBITDA 2022: -$3.92B
Illumina EBITDA in 2022 was -$3.92B, plunged 427.4% below 2021. This figure represents the lowest annual value in the available history.
Illumina EBITDA 2021: $1.20B
Illumina EBITDA in 2021 was $1.20B.
See more financial history for Illumina (ILMN).
Sector peers — EBITDA
Companies in the same sector as Illumina, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Illumina's EBITDA?
- Latest reported EBITDA for Illumina (ILMN) is $1.46B (period ending December 28, 2025).
How has Illumina EBITDA changed year-over-year?
- Illumina (ILMN) EBITDA changed -301.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Illumina EBITDA?
- Illumina (ILMN) EBITDA compound annual growth rate is +5.9% over the most recent 5 years available.
When did Illumina EBITDA hit its highest annual value?
- Illumina EBITDA reached its highest annual value of $1.46B in 2025.
What was Illumina EBITDA in 2024?
- Illumina (ILMN) EBITDA in 2024 was -$725.00M.
What was Illumina EBITDA in 2025?
- Illumina (ILMN) EBITDA in 2025 was $1.46B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ILMN Overview
Company profile, financial tools, and key metrics
ILMN Revenue Counter
Earns $137.68 every second. See per minute, hour, and day.
ILMN Earnings Counter
Earns $26.95 per second net profit. See per minute, hour, and day.
ILMN Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
ILMN What If Invested
What if you had invested $1,000? See historical returns from any date.
ILMN How It Makes Money
Discover visual breakdown of $4.34B in revenue — where it comes from and where it goes.
ILMN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ILMN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ILMN Daily Price Character
Explosive · 50.0% historical win rate (green days). Streaks & record days.
ILMN Buybacks
3.61% TTM buyback yield. Shareholder yield & SBC comparison.
ILMN Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.